Shares in Hikma Pharmaceuticals fell after the company cut core operating profit guidance for the year and lowered its midterm outlook. Shares in early European trade were down 220 pence, or 12%, at 1 ...

CFAO Healthcare South Africa proudly announces that it has attained a Level 3 Broad-Based Black Economic Empowerment (B-BBEE) ...

KUWAIT CITY, Nov 6: Developing an advanced local pharmaceutical industry is a cornerstone of Kuwait’s healthcare “flexibility ...

Expanding Access to Lyophilized Therapies: Reunite removes reliance on vial kits and manual reconstitution, making ...

Piramal Pharma reported a consolidated net loss of Rs 99.22 crore in Q2 FY26, compared with a net profit of Rs 22.59 crore recorded in Q2 FY25.

Leading drugmaker Sun Pharma is doubling down on its specialty portfolio, launching new products and ramping up ...

Jushi Holdings (JUSHF) remains unprofitable but has trimmed its losses by an average of 15% per year over the past five years, with revenue projected to grow 8.1% per year. This is slower than the ...

The South Australian plant is at the centre of debate over whether a $672 million takeover of the entire business can proceed ...

Royalty Pharma PLC ( ($RPRX) ) has released its Q3 earnings. Here is a breakdown of the information Royalty Pharma PLC presented to its investors.

Investing in pharmaceutical companies with robust product pipelines and diversified revenue streams is often considered a ...